Journal of Child Psychology and Psychiatry

Cover image for Vol. 58 Issue 3

Edited By: Edmund Sonuga-Barke

Impact Factor: 6.615

ISI Journal Citation Reports © Ranking: 2015: 2/69 (Psychology Developmental); 6/76 (Psychology); 8/139 (Psychiatry (Social Science)); 10/142 (Psychiatry)

Online ISSN: 1469-7610

Associated Title(s): Child and Adolescent Mental Health

Author Guidelines

Please read the Notes for Contributors guidance below for all types of contributions and styles of manuscript. There is also specific guidance available on Practitioner Reviews and Research Reviews.

Why submit your article to The Journal of Child Psychology and Psychiatry?

  • The leading, international journal covering both child and adolescent psychology and psychiatry;

  • Provides an interdisciplinary perspective to the multidisciplinary field of child and adolescent mental health, though publication of high-quality empirical research, clinically-relevant studies and highly cited research reviews and practitioner review articles;

  • The journal reached an all time high in the most recent release of impact factors: Impact Factor 6.459 (2014); 5-Year Impact Factor 6.681 (2014): ISI Journal Citation Reports © Ranking: 2014: 2/68 (Psychology, Developmental); 7/76 (Psychology); 9/133 (Psychiatry (Social Science)); 13/140 (Psychiatry);

  • Ranked in the Top 20 journals in psychiatry and psychology by citation impact over the last decade (Thomson Reuters, Essential Science Indicators);

  • Over 9,000 institutions with access to current content;

  • Massive international readership; nearly one million articles downloaded every year (37% North America, 31% Europe, 10% Asia-Pacific);

  • Quick turnaround times:

    · Decision on your paper in around 5 weeks (excluding reject without review decisions).
    · On average, articles are published online within 6 months from initial submission.

  • Articles appear on Early View before the paper version is published – Click here; to see the Early View articles currently available online; Epub entries on PubMed and widely indexed/abstracted, including MEDLINE, EMBASE and ISI Citation Indexes;

  • Acceptance to Early View publication approx. 6 weeks; Acceptance to print publication approx. 5 months;

  • Every manuscript is assigned to 1 of the 8 decision editors specialising in a particular subject domain. Acceptance rate is around 18%;

  • State of the art online submission site, simple and quick to use:-; dedicated journal Editorial Office for easy, personal contact through the peer review and editorial process; proof tracking tool for authors. All papers published in JCPP are eligible for Panel A: Psychology, Psychiatry and Neuroscience in the Research Excellence Framework (REF);

Notes for Contributors


Contributions from any discipline that further knowledge of the mental health and behaviour of children and adolescents are welcomed. Papers are published in English, but submissions are welcomed from any country. Contributions should be of a standard that merits presentation before an international readership.

Papers may assume either of the following forms:

  • Original articles
    These should make an original contribution to empirical knowledge, to the theoretical understanding of the subject, or to the development of clinical research and practice. Adult data are not usually accepted for publication unless they bear directly on developmental issues in childhood and adolescence. Original articles should not exceed 6000 words, including title page, abstract, references, tables, and figures; the total word count should be given on the title page of the manuscript. Limit tables and figures to 5 or fewer double-spaced manuscript pages. It is possible to submit additional tables or figures as an Appendix for an online-only version. Manuscripts exceeding the word limit will not be accepted without permission from the Editor.
  • Review articles
    These should survey an important area of interest within the general field. These include papers in the Annual Research Review, Research Review and Practitioner Review sections, which are usually commissioned. Word limits for review papers are stated at the time of commissioning.

Authors’ professional and ethical responsibilities

Submission of a paper to JCPP will be held to imply that it represents an original contribution not previously published (except in the form of an abstract or preliminary report); that it is not being considered for publication elsewhere; and that, if accepted by the Journal, it will not be published elsewhere in the same form, in any language, without the consent of the Editors. When submitting a manuscript, authors should state in a covering letter whether they have currently in press, submitted or in preparation any other papers that are based on the same data set, and, if so, provide details for the Editors.

Authors are reminded that the Journal adheres to the ethics of scientific publication as detailed in the
Ethical principles of psychologists and code of conduct (American Psychological Association, 2010). These principles also imply that the piecemeal, or fragmented publication of small amounts of data from the same study is not acceptable. The Journal also generally conforms to the Uniform Requirements for Manuscripts  of the International Committee of Medical Journal Editors (ICJME) and is also a member and subscribes to the principles of the Committee on Publication Ethics (COPE).

Authorship credit should be given only if substantial contribution has been made to the following:

· Conception and design, or collection, analysis and interpretation of data

· Drafting the article or revising it critically for important intellectual content, and final approval of the version to be published

The corresponding author must ensure that there is no one else who fulfils the criteria who is not included as an author. Each author is required to have participated sufficiently in the work to take public responsibility for the content.

Conflict of interest
All submissions to JCPP require a declaration of interest. This should list fees and grants from, employment by, consultancy for, shared ownership in, or any close relationship with, an organisation whose interests, financial or otherwise, may be affected by the publication of the paper. This pertains to all authors, and all conflict of interest should be noted on page 1 of the submitted manuscript. Where there is no conflict of interest, this should also be stated. The JCPP Editor Conflict of Interest Statement can be found by clicking here. The JCPP Editor Conflicts of Interest Statement is published annually in issue 1 of each volume.

Note to NIH Grantees
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see

Informed consent and ethics approval

Authors must ensure that all research meets these ethical guidelines and affirm that the research has received permission from a stated Research Ethics Committee (REC) or Institutional Review Board (IRB), including adherence to the legal requirements of the study county. Within the Methods section, authors should indicate that ‘informed consent’ has been appropriately obtained and state the name of the REC, IRB or other body that provided ethical approval. When submitting a manuscript, the manuscript page number where these statements appear should be given.

Recommended guidelines and standards

The Journal requires authors to conform to CONSORT 2010 (see
CONSORT Statement) in relation to the reporting of randomised controlled clinical trials; also recommended is the Extensions of the CONSORT Statement with regard to cluster randomised controlled trials). In particular, authors must include in their paper a flow chart illustrating the progress of subjects through the trial (CONSORT diagram) and the CONSORT checklist. The flow diagram should appear in the main paper, the checklist in the online Appendix. Trial registry name, registration identification number, and the URL for the registry should also be included at the end of the methods section of the Abstract and again in the Methods section of the main text, and in the online manuscript submission. Trials should be registered in one of the ICJME-recognised  trial registries:

Australian Clinical Trials Registry
Clinical Trials
ISRCTN Register
Nederlands Trial Register
UMIN Clinical Trials Registry

Manuscripts reporting systematic reviews or meta-analyses should conform to the PRISMA Statement. The Equator Network is recommended as a resource on the above and other reporting guidelines.

Access to data
If the study includes original data, at least one author must confirm that he or she had full access to all the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis.

An initiative started by CrossRef to help its members actively engage in efforts to prevent scholarly and professional plagiarism. The journal to which you are submitting your manuscript employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

Manuscript preparation and submission

Papers should be submitted online. For detailed instructions please go to: Previous users can check for existing account. New users should create a new account. Help with submitting online can be obtained from the Editorial Office at

1. The manuscript should be double spaced throughout, including references and tables. Pages should be numbered consecutively.  The preferred file formats are MS Word or WordPerfect, and should be PC compatible. If using other packages the file should be saved as Rich Text Format or Text only.

2. Papers should be concise and written in English in a readily understandable style. Care should be taken to avoid racist or sexist language, and statistical presentation should be clear and unambiguous. The Journal follows the style recommendations given in the Publication manual of the American Psychological Association (5th edn., 2001).

3. The Journal is not able to offer a translation service, but, authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English. A list of independent suppliers of editing services can be found at All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.

The first page of the manuscript should give the title, name(s) and short address(es) of author(s), and an abbreviated title (for use as a running head) of up to 60 characters.

Abstract: The abstract should not exceed 300 words and should be structured in the following way with bold marked headings: Background; Methods; Results; Conclusions; Keywords; Abbreviations. The abbreviations will apply where authors are using acronyms for tests or abbreviations not in common usage. 

Key points: All papers should include a text box at the end of the manuscript outlining the four to five Key (bullet) points of the paper. These should briefly (80-120 words) outline what’s known, what’s new, and what’s clinically relevant.

Headings: Articles and research reports should be set out in the conventional format: Methods, Results, Discussion and Conclusion. Descriptions of techniques and methods should only be given in detail when they are unfamiliar. There should be no more than three (clearly marked) levels of subheadings used in the text. 

Acknowledgements: These should appear at the end of the main text, before the References.

Correspondence to: Full name, address, phone, fax and email details of the corresponding author should appear at the end of the main text, before the References.

The JCPP follows the text referencing style and reference list style detailed in the Publication manual of the American Psychological Association (5th edn.)i.

References in text: References in running text should be quoted as follows:
Smith and Brown (1990), or (Smith, 1990), or (Smith, 1980, 1981a, b), or (Smith & Brown, 1982), or (Brown & Green, 1983; Smith, 1982).

For up to five authors, all surnames should be cited in the first instance, with subsequent occurrences cited as et al., e.g. Smith et al. (1981) or (Smith et al., 1981). For six or more authors, cite only the surname of the first author followed by et al. However, all authors should be listed in the Reference List. Join the names in a multiple author citation in running text by the word ‘and’. In parenthetical material, in tables, and in the References List, join the names by an ampersand (&). References to unpublished material should be avoided.

Reference list: Full references should be given at the end of the article in alphabetical order, and not in footnotes. Double spacing must be used.

References to journals should include the authors’ surnames and initials, the year of publication, the full title of the paper, the full name of the journal, the volume number, and inclusive page numbers. Titles of journals must not be abbreviated and should be italicised.

References to books should include the authors’ surnames and initials, the year of publication, the full title of the book, the place of publication, and the publisher's name.

References to articles, chapters and symposia contributions should be cited as per the examples below:

Kiernan, C. (1981). Sign language in autistic children. Journal of Child Psychology and Psychiatry, 22, 215-220.

Thompson, A. (1981). Early experience: The new evidence. Oxford: Pergamon Press.

Jones, C.C., & Brown, A. (1981). Disorders of perception. In K. Thompson (Ed.), Problems in early childhood (pp. 23-84). Oxford: Pergamon Press.

Use Ed.(s) for Editor(s); edn. for edition; p.(pp.) for page(s); Vol. 2 for Volume 2.

Tables and Figures
All Tables and Figures should appear at the end of main text and references, but have their intended position clearly indicated in the manuscript. They should be constructed so as to be intelligible without reference to the text. Any lettering or line work should be able to sustain reduction to the final size of reproduction. Tints and complex shading should be avoided and colour should not be used unless essential. Figures should be originated in a drawing package and saved as TIFF, EPS, or PDF files. Further information about supplying electronic artwork can be found in the Wiley-Blackwell electronic artwork guidelines at

Nomenclature and symbols
Each paper should be consistent within itself as to nomenclature, symbols and units. When referring to drugs, give generic names, not trade names. Greek characters should be clearly indicated.

Manuscript processing

The Journal has a policy of anonymous peer review and the initial refereeing process seldom requires more than three months. Most manuscripts will require some revision by the authors before final acceptance. The Editorial decision on the suitability of a manuscript for publication is final.  

Proofs will be sent to the designated author only. These will be sent via email as a PDF file, and therefore a current email address must be provided with the manuscript. Only typographical or factual errors may be changed at proof stage. The publisher reserves the right to charge authors for correction of non-typographical errors.  

The designated author of a published paper will receive a PDF file of their final published article. The designated author should undertake to forward copies of the PDF file to their co-authors. 

If your paper is accepted, the author identified as the corresponding author for the paper will receive an email prompting them to log into Author Services where, via the Wiley Author Licensing Service (WALS), they will be able to complete a license agreement on behalf of all co-authors of the paper.

For authors who do not chose OnlineOpen

If the OnlineOpen option is not selected, the corresponding author will be presented with the Copyright Transfer Agreement (CTA) to sign. The terms and conditions of the CTA can be previewed in the Copyright FAQs here.

For authors choosing OnlineOpen

If the OnlineOpen option is selected, the corresponding author will have a choice of the following Creative Commons License Open Access Agreemenets (OAA):

Creative Commons Attribution License OAA

Creative Commons Attribution Non-Commercial License OAA

Creative Commons Attribution Non-Commercial-NoDervivs License OAA

To preview the terms and conditions of these Open Access Agreements please visit the Copyright FAQs here and click here for more information.

If you select the OnlineOpen option and your research is funded by certain Funders [e.g. The Wellcome Trust and members of the Research Councils UK (RCUK) or the Austrian Science Fund (FWF)] you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with your Funder requirements.

For more information on this policy and the journal's compliant self-archiving policy please click here.


Whilst every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinion or statement appears in this journal, they wish to make it clear that the data and opinions appearing in the articles and advertisements herein are the sole responsibility of the contributor or advertiser concerned. Accordingly, the publishers, the editorial board and editors, and their respective employees, officers and agents accept no responsibility or liability whatsoever for the consequences of any such inaccurate or misleading data, opinion or statement. 

Appeals Process

1. If your manuscript is rejected, and if you believe a pertinent point was overlooked or misunderstood by the decision Editor or reviewers, you may appeal the editorial decision by contacting the decision Editor through the Editorial Office at with “Appeal against rejection decision Ms Ref : JCPP-XX-20YY-00###” in the email subject line.

2. If you appeal to the decision Editor and are not satisfied with the Editor's response, a second-step appeal may be considered by the Editor-in-Chief, whose decision will be final.